Dason, E. S.
Drost, L.
Greenblatt, E. M.
Scheer, A. S.
Han, J.
Sobel, M.
Allen, L.
Jacobson, M.
Doshi, T.
Wolff, E.
McMahon, E.
Jones, C. A.
Article History
Received: 22 June 2022
Accepted: 22 November 2022
First Online: 8 December 2022
Declarations
:
: We received institutional review board approval from Mount Sinai Hospital (2018-0086-E) and Women’s College Hospital (2018-0050-E). Informed consent was obtained from all participants. This research was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: EM is a paid consultant for EMD Serono and performs expert review of nurse education modules. CJ is the program director for the GREI Fellowship at the University of Toronto; the fellowship fund, which supports academic endeavors, receives payments from EMD Serono and Ferring Canada. MJ has received grants from CIHR and the US Department of Defense. MJ has received consulting fees from Biosyent, Pfizer and Duchesnay. MJ has received payment from Biosyent, Pfizer, Allergan, Merck and Bayer for speaking engagements. She has received support for participating on a drug safety monitoring board or advisory board and attending meetings from Pfizer and Biosyent. MJ also holds a leadership role in Cancer Care Ontario and the Society for Obstetricians and Gynaecologists of Canada. All other authors declare no competing interests.